Compound ID | 1341
Class: Beta-lactam (penicillin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Beta-Lactamase resistant. primarily for the treatment of multiple drug-resistant, Gram-Negative bacteria. Not active against Gram-positive bacteria or bacteria with altered penicillin-binding proteins |
| Institute where first reported: | Beecham Pharmaceuticals (GSK, US) |
| Year first mentioned: | 1982 |
| Highest developmental phase: | Phase 4 |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/171758 |
| Guide to Pharmacology: | temocillin |
| Citations: |
|